Global Diagnostic Radiopharmaceuticals & Contrast Media Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Diagnostic Radiopharmaceuticals & Contrast Media market size was valued at US$ 9564.3 million in 2023. With growing demand in downstream market, the Diagnostic Radiopharmaceuticals & Contrast Media is forecast to a readjusted size of US$ 11980 million by 2030 with a CAGR of 3.3% during review period.
The research report highlights the growth potential of the global Diagnostic Radiopharmaceuticals & Contrast Media market. Diagnostic Radiopharmaceuticals & Contrast Media are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Diagnostic Radiopharmaceuticals & Contrast Media. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Diagnostic Radiopharmaceuticals & Contrast Media market.
Key Features:
The report on Diagnostic Radiopharmaceuticals & Contrast Media market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Diagnostic Radiopharmaceuticals & Contrast Media market. It may include historical data, market segmentation by Type (e.g., Radiopharmaceuticals, Contrast Media), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Diagnostic Radiopharmaceuticals & Contrast Media market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Diagnostic Radiopharmaceuticals & Contrast Media market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Diagnostic Radiopharmaceuticals & Contrast Media industry. This include advancements in Diagnostic Radiopharmaceuticals & Contrast Media technology, Diagnostic Radiopharmaceuticals & Contrast Media new entrants, Diagnostic Radiopharmaceuticals & Contrast Media new investment, and other innovations that are shaping the future of Diagnostic Radiopharmaceuticals & Contrast Media.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Diagnostic Radiopharmaceuticals & Contrast Media market. It includes factors influencing customer ' purchasing decisions, preferences for Diagnostic Radiopharmaceuticals & Contrast Media product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Diagnostic Radiopharmaceuticals & Contrast Media market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Diagnostic Radiopharmaceuticals & Contrast Media market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Diagnostic Radiopharmaceuticals & Contrast Media market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Diagnostic Radiopharmaceuticals & Contrast Media industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Diagnostic Radiopharmaceuticals & Contrast Media market.
Market Segmentation:
Diagnostic Radiopharmaceuticals & Contrast Media market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Diagnostic Radiopharmaceuticals & Contrast Media market?
What factors are driving Diagnostic Radiopharmaceuticals & Contrast Media market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diagnostic Radiopharmaceuticals & Contrast Media market opportunities vary by end market size?
How does Diagnostic Radiopharmaceuticals & Contrast Media break out type, application?
According to our LPI (LP Information) latest study, the global Diagnostic Radiopharmaceuticals & Contrast Media market size was valued at US$ 9564.3 million in 2023. With growing demand in downstream market, the Diagnostic Radiopharmaceuticals & Contrast Media is forecast to a readjusted size of US$ 11980 million by 2030 with a CAGR of 3.3% during review period.
The research report highlights the growth potential of the global Diagnostic Radiopharmaceuticals & Contrast Media market. Diagnostic Radiopharmaceuticals & Contrast Media are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Diagnostic Radiopharmaceuticals & Contrast Media. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Diagnostic Radiopharmaceuticals & Contrast Media market.
Key Features:
The report on Diagnostic Radiopharmaceuticals & Contrast Media market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Diagnostic Radiopharmaceuticals & Contrast Media market. It may include historical data, market segmentation by Type (e.g., Radiopharmaceuticals, Contrast Media), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Diagnostic Radiopharmaceuticals & Contrast Media market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Diagnostic Radiopharmaceuticals & Contrast Media market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Diagnostic Radiopharmaceuticals & Contrast Media industry. This include advancements in Diagnostic Radiopharmaceuticals & Contrast Media technology, Diagnostic Radiopharmaceuticals & Contrast Media new entrants, Diagnostic Radiopharmaceuticals & Contrast Media new investment, and other innovations that are shaping the future of Diagnostic Radiopharmaceuticals & Contrast Media.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Diagnostic Radiopharmaceuticals & Contrast Media market. It includes factors influencing customer ' purchasing decisions, preferences for Diagnostic Radiopharmaceuticals & Contrast Media product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Diagnostic Radiopharmaceuticals & Contrast Media market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Diagnostic Radiopharmaceuticals & Contrast Media market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Diagnostic Radiopharmaceuticals & Contrast Media market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Diagnostic Radiopharmaceuticals & Contrast Media industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Diagnostic Radiopharmaceuticals & Contrast Media market.
Market Segmentation:
Diagnostic Radiopharmaceuticals & Contrast Media market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Radiopharmaceuticals
- Contrast Media
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amag Pharmaceuticals
- Bayer Healthcare
- Bracco Imaging
- Daiichi Sankyo
- GE Healthcare
- Guerbet
- Lantheus
- Mallinckrodt
- Medtronic
- Nordion
What is the 10-year outlook for the global Diagnostic Radiopharmaceuticals & Contrast Media market?
What factors are driving Diagnostic Radiopharmaceuticals & Contrast Media market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diagnostic Radiopharmaceuticals & Contrast Media market opportunities vary by end market size?
How does Diagnostic Radiopharmaceuticals & Contrast Media break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Country/Region, 2019, 2023 & 2030
2.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
2.2.1 Radiopharmaceuticals
2.2.2 Contrast Media
2.3 Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
2.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
2.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Type (2019-2024)
2.3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Type (2019-2024)
2.4 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
2.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Market Share by Application (2019-2024)
2.5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Application (2019-2024)
2.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Application (2019-2024)
3 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA BY COMPANY
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Breakdown Data by Company
3.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales by Company (2019-2024)
3.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Company (2019-2024)
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue by Company (2019-2024)
3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2019-2024)
3.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Company (2019-2024)
3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Company
3.4 Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Product Location Distribution
3.4.2 Players Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA BY GEOGRAPHIC REGION
4.1 World Historic Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Geographic Region (2019-2024)
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country/Region (2019-2024)
4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales by Country/Region (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue by Country/Region (2019-2024)
4.3 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
4.4 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
4.5 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
4.6 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
5 AMERICAS
5.1 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
5.1.1 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024)
5.1.2 Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024)
5.2 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
5.3 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
6.1.1 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019-2024)
6.1.2 APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2019-2024)
6.2 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
6.3 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media by Country
7.1.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024)
7.1.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024)
7.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media by Country
8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024)
8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024)
8.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
8.3 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
10.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
10.4 Industry Chain Structure of Diagnostic Radiopharmaceuticals & Contrast Media
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors
11.3 Diagnostic Radiopharmaceuticals & Contrast Media Customer
12 WORLD FORECAST REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA BY GEOGRAPHIC REGION
12.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast by Region
12.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecast by Region (2025-2030)
12.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecast by Type
12.7 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amag Pharmaceuticals
13.1.1 Amag Pharmaceuticals Company Information
13.1.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Amag Pharmaceuticals Main Business Overview
13.1.5 Amag Pharmaceuticals Latest Developments
13.2 Bayer Healthcare
13.2.1 Bayer Healthcare Company Information
13.2.2 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Healthcare Main Business Overview
13.2.5 Bayer Healthcare Latest Developments
13.3 Bracco Imaging
13.3.1 Bracco Imaging Company Information
13.3.2 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bracco Imaging Main Business Overview
13.3.5 Bracco Imaging Latest Developments
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Information
13.4.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Daiichi Sankyo Main Business Overview
13.4.5 Daiichi Sankyo Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Guerbet
13.6.1 Guerbet Company Information
13.6.2 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Guerbet Main Business Overview
13.6.5 Guerbet Latest Developments
13.7 Lantheus
13.7.1 Lantheus Company Information
13.7.2 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lantheus Main Business Overview
13.7.5 Lantheus Latest Developments
13.8 Mallinckrodt
13.8.1 Mallinckrodt Company Information
13.8.2 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mallinckrodt Main Business Overview
13.8.5 Mallinckrodt Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Nordion
13.10.1 Nordion Company Information
13.10.2 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nordion Main Business Overview
13.10.5 Nordion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Country/Region, 2019, 2023 & 2030
2.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
2.2.1 Radiopharmaceuticals
2.2.2 Contrast Media
2.3 Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
2.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
2.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Type (2019-2024)
2.3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Type (2019-2024)
2.4 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
2.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Market Share by Application (2019-2024)
2.5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Application (2019-2024)
2.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Application (2019-2024)
3 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA BY COMPANY
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Breakdown Data by Company
3.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales by Company (2019-2024)
3.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Company (2019-2024)
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue by Company (2019-2024)
3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2019-2024)
3.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Company (2019-2024)
3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Company
3.4 Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Product Location Distribution
3.4.2 Players Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA BY GEOGRAPHIC REGION
4.1 World Historic Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Geographic Region (2019-2024)
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country/Region (2019-2024)
4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales by Country/Region (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue by Country/Region (2019-2024)
4.3 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
4.4 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
4.5 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
4.6 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth
5 AMERICAS
5.1 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
5.1.1 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024)
5.1.2 Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024)
5.2 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
5.3 Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
6.1.1 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019-2024)
6.1.2 APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2019-2024)
6.2 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
6.3 APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media by Country
7.1.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024)
7.1.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024)
7.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media by Country
8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024)
8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024)
8.2 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
8.3 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
10.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
10.4 Industry Chain Structure of Diagnostic Radiopharmaceuticals & Contrast Media
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors
11.3 Diagnostic Radiopharmaceuticals & Contrast Media Customer
12 WORLD FORECAST REVIEW FOR DIAGNOSTIC RADIOPHARMACEUTICALS & CONTRAST MEDIA BY GEOGRAPHIC REGION
12.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast by Region
12.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecast by Region (2025-2030)
12.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecast by Type
12.7 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amag Pharmaceuticals
13.1.1 Amag Pharmaceuticals Company Information
13.1.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Amag Pharmaceuticals Main Business Overview
13.1.5 Amag Pharmaceuticals Latest Developments
13.2 Bayer Healthcare
13.2.1 Bayer Healthcare Company Information
13.2.2 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Healthcare Main Business Overview
13.2.5 Bayer Healthcare Latest Developments
13.3 Bracco Imaging
13.3.1 Bracco Imaging Company Information
13.3.2 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bracco Imaging Main Business Overview
13.3.5 Bracco Imaging Latest Developments
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Information
13.4.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Daiichi Sankyo Main Business Overview
13.4.5 Daiichi Sankyo Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Guerbet
13.6.1 Guerbet Company Information
13.6.2 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Guerbet Main Business Overview
13.6.5 Guerbet Latest Developments
13.7 Lantheus
13.7.1 Lantheus Company Information
13.7.2 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lantheus Main Business Overview
13.7.5 Lantheus Latest Developments
13.8 Mallinckrodt
13.8.1 Mallinckrodt Company Information
13.8.2 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mallinckrodt Main Business Overview
13.8.5 Mallinckrodt Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Nordion
13.10.1 Nordion Company Information
13.10.2 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
13.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nordion Main Business Overview
13.10.5 Nordion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Radiopharmaceuticals
Table 4. Major Players of Contrast Media
Table 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2019-2024) & ($ million)
Table 8. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2019-2024)
Table 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Table 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2019-2024)
Table 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2019-2024)
Table 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2019-2024) & (K Units)
Table 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Company (2019-2024)
Table 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Company (2019-2024)
Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Producing Area Distribution and Sales Area
Table 21. Players Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
Table 22. Diagnostic Radiopharmaceuticals & Contrast Media Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Geographic Region (2019-2024)
Table 27. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country/Region (2019-2024)
Table 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
Table 34. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2024)
Table 35. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2024)
Table 37. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 38. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 39. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019-2024) & (K Units)
Table 40. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2019-2024)
Table 41. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2019-2024)
Table 43. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 44. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 45. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
Table 46. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2024)
Table 47. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2024)
Table 49. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 50. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Diagnostic Radiopharmaceuticals & Contrast Media
Table 58. Key Market Challenges & Risks of Diagnostic Radiopharmaceuticals & Contrast Media
Table 59. Key Industry Trends of Diagnostic Radiopharmaceuticals & Contrast Media
Table 60. Diagnostic Radiopharmaceuticals & Contrast Media Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
Table 63. Diagnostic Radiopharmaceuticals & Contrast Media Customer List
Table 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Amag Pharmaceuticals Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 79. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 80. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Amag Pharmaceuticals Main Business
Table 82. Amag Pharmaceuticals Latest Developments
Table 83. Bayer Healthcare Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 85. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Bayer Healthcare Main Business
Table 87. Bayer Healthcare Latest Developments
Table 88. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 89. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 90. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Bracco Imaging Main Business
Table 92. Bracco Imaging Latest Developments
Table 93. Daiichi Sankyo Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 95. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 99. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 100. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. GE Healthcare Main Business
Table 102. GE Healthcare Latest Developments
Table 103. Guerbet Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 104. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 105. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Guerbet Main Business
Table 107. Guerbet Latest Developments
Table 108. Lantheus Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 109. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 110. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Lantheus Main Business
Table 112. Lantheus Latest Developments
Table 113. Mallinckrodt Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 114. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 115. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Mallinckrodt Main Business
Table 117. Mallinckrodt Latest Developments
Table 118. Medtronic Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 120. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Medtronic Main Business
Table 122. Medtronic Latest Developments
Table 123. Nordion Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 124. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 125. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Nordion Main Business
Table 127. Nordion Latest Developments
Table 1. Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Diagnostic Radiopharmaceuticals & Contrast Media Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Radiopharmaceuticals
Table 4. Major Players of Contrast Media
Table 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2019-2024) & ($ million)
Table 8. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2019-2024)
Table 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Table 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2019-2024)
Table 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2019-2024)
Table 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2019-2024) & (K Units)
Table 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Company (2019-2024)
Table 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Company (2019-2024)
Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Producing Area Distribution and Sales Area
Table 21. Players Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
Table 22. Diagnostic Radiopharmaceuticals & Contrast Media Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Geographic Region (2019-2024)
Table 27. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country/Region (2019-2024)
Table 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
Table 34. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2024)
Table 35. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2024)
Table 37. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 38. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 39. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019-2024) & (K Units)
Table 40. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2019-2024)
Table 41. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2019-2024)
Table 43. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 44. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 45. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
Table 46. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2024)
Table 47. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2024)
Table 49. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 50. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Diagnostic Radiopharmaceuticals & Contrast Media
Table 58. Key Market Challenges & Risks of Diagnostic Radiopharmaceuticals & Contrast Media
Table 59. Key Industry Trends of Diagnostic Radiopharmaceuticals & Contrast Media
Table 60. Diagnostic Radiopharmaceuticals & Contrast Media Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
Table 63. Diagnostic Radiopharmaceuticals & Contrast Media Customer List
Table 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Amag Pharmaceuticals Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 79. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 80. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Amag Pharmaceuticals Main Business
Table 82. Amag Pharmaceuticals Latest Developments
Table 83. Bayer Healthcare Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 85. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Bayer Healthcare Main Business
Table 87. Bayer Healthcare Latest Developments
Table 88. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 89. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 90. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Bracco Imaging Main Business
Table 92. Bracco Imaging Latest Developments
Table 93. Daiichi Sankyo Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 95. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Daiichi Sankyo Main Business
Table 97. Daiichi Sankyo Latest Developments
Table 98. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 99. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 100. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. GE Healthcare Main Business
Table 102. GE Healthcare Latest Developments
Table 103. Guerbet Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 104. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 105. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Guerbet Main Business
Table 107. Guerbet Latest Developments
Table 108. Lantheus Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 109. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 110. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Lantheus Main Business
Table 112. Lantheus Latest Developments
Table 113. Mallinckrodt Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 114. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 115. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Mallinckrodt Main Business
Table 117. Mallinckrodt Latest Developments
Table 118. Medtronic Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 120. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Medtronic Main Business
Table 122. Medtronic Latest Developments
Table 123. Nordion Basic Information, Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base, Sales Area and Its Competitors
Table 124. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolios and Specifications
Table 125. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Nordion Main Business
Table 127. Nordion Latest Developments
LIST OF FIGURES
Figure 1. Picture of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 2. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Radiopharmaceuticals
Figure 10. Product Picture of Contrast Media
Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type in 2023
Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2019-2024)
Figure 13. Diagnostic Radiopharmaceuticals & Contrast Media Consumed in Hospital
Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Market: Hospital (2019-2024) & (K Units)
Figure 15. Diagnostic Radiopharmaceuticals & Contrast Media Consumed in Clinic
Figure 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Market: Clinic (2019-2024) & (K Units)
Figure 17. Diagnostic Radiopharmaceuticals & Contrast Media Consumed in Other
Figure 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Market: Other (2019-2024) & (K Units)
Figure 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2023)
Figure 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application in 2023
Figure 21. Diagnostic Radiopharmaceuticals & Contrast Media Sales Market by Company in 2023 (K Units)
Figure 22. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Company in 2023
Figure 23. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Company in 2023
Figure 25. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 28. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 29. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 30. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 31. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 32. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 35. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country in 2023
Figure 36. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country in 2023
Figure 37. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 38. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 39. United States Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region in 2023
Figure 44. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions in 2023
Figure 45. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 46. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 47. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country in 2023
Figure 55. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country in 2023
Figure 56. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 57. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 58. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 67. Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals & Contrast Media in 2023
Figure 73. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 74. Industry Chain Structure of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 75. Channels of Distribution
Figure 76. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Forecast by Region (2025-2030)
Figure 77. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 2. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Radiopharmaceuticals
Figure 10. Product Picture of Contrast Media
Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type in 2023
Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2019-2024)
Figure 13. Diagnostic Radiopharmaceuticals & Contrast Media Consumed in Hospital
Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Market: Hospital (2019-2024) & (K Units)
Figure 15. Diagnostic Radiopharmaceuticals & Contrast Media Consumed in Clinic
Figure 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Market: Clinic (2019-2024) & (K Units)
Figure 17. Diagnostic Radiopharmaceuticals & Contrast Media Consumed in Other
Figure 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Market: Other (2019-2024) & (K Units)
Figure 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2023)
Figure 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application in 2023
Figure 21. Diagnostic Radiopharmaceuticals & Contrast Media Sales Market by Company in 2023 (K Units)
Figure 22. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Company in 2023
Figure 23. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Company in 2023
Figure 25. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 28. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 29. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 30. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 31. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 32. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2024 ($ Millions)
Figure 35. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country in 2023
Figure 36. Americas Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country in 2023
Figure 37. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 38. Americas Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 39. United States Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region in 2023
Figure 44. APAC Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions in 2023
Figure 45. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 46. APAC Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 47. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country in 2023
Figure 55. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country in 2023
Figure 56. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 57. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 58. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
Figure 67. Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals & Contrast Media in 2023
Figure 73. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 74. Industry Chain Structure of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 75. Channels of Distribution
Figure 76. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Forecast by Region (2025-2030)
Figure 77. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Application (2025-2030)
